about
Treatment of hepatocellular carcinoma: Steps forward but still a long way to goHepatocellular carcinoma: a reviewAssessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patientsPulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinomaThe neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma.Observation of the effect of targeted therapy of 64-slice spiral CT combined with cryoablation for liver cancer.Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition.Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133.Diagnosis and treatment of hepatocellular carcinoma: An update.Locoregional and systemic therapy for hepatocellular carcinoma.Extremely elevated alpha-fetoprotein due to acute exacerbation of chronic hepatitis B without malignancy: a case reportForce-dependent breaching of the basement membrane.A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.VEGF Polymorphisms Related to Higher Serum Levels of Protein Identify Patients with Hepatocellular Carcinoma.Advances and Future Directions in the Treatment of Hepatocellular CarcinomaDes-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis.Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells.Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.TGF-β2-induced EMT is dampened by inhibition of autophagy and TNF-α treatment.Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies.Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization.Surveillance for Hepatocellular Carcinoma.Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review.Study to evaluate the immunomodulatory effects of radiofrequency ablation compared to surgical resection for liver cancer
P2860
Q26865456-C702C4E8-CB81-4AAA-9CB4-AF4C71981894Q28069290-A0C96E93-50E6-41AB-9678-95E5DA4BA382Q28086977-817F3D41-02BA-4601-BC4C-ADCF3F3CC1E8Q28818507-AA7C1EDB-CDFC-4C6A-AF4F-AFFE594E14F3Q33566593-AD879F4B-9135-4878-A0A7-01881C2A90AAQ33805911-DC2C0A7D-A699-4F5A-ABCF-0ACDCE13C414Q35270193-97A9731A-66AA-4B21-959C-2E9C3795743CQ36724357-A848AD22-D4D1-47F5-8D56-4ADDB128E18EQ37129347-73679E84-09B0-4553-82DA-3E8ACB47B98DQ37734673-6CAFDAEB-6A44-4FDE-A1AC-E5033BB349BEQ38408866-630544C1-5CF4-412A-9161-CD81B5489554Q38686790-DB01E5C1-EA93-4A21-A87C-50ED7DEADB2BQ38849500-E241C38C-79BE-459D-9F0E-A9F933905B85Q39056693-85674AE4-7637-4425-8BC9-3936776EBA1CQ40084991-6EF27C5B-539A-4AC0-B633-D679AB885232Q41083020-1C9BAF34-3471-4874-A6C9-B7BC8F66C3BDQ41531360-B5C809AB-8E30-4AA9-A9B5-FF732A418D5EQ41667581-2872DDA6-4893-4601-AA4C-096D4D8BBC52Q47117446-3DF29E3A-DE72-474B-898E-F3D0A629ED6FQ47139887-F9B5FD7F-DEB3-4E7A-BFAE-BCCC5C66E5EBQ47216499-A8D709A3-A883-4730-85AE-921CEF09668BQ49725940-A54A626E-B3C8-4608-9FF2-130F302BA4EDQ49787444-11386CC9-819C-4613-85AE-7C1863E3104CQ51743178-C7DB47C5-3E2A-49F6-BC8F-0736E27771F1Q55077255-D7902273-010F-4B27-92A4-E0AFB852D4ADQ55154228-73BC8432-C7E2-4B92-97C3-FB91DD6EA988Q55268879-6E9E4493-4881-43E8-A2D2-C83AA4CA202BQ58798362-0269E1E8-8DBB-4F45-AD1A-DCA1C9968F70
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Current management of hepatocellular carcinoma.
@ast
Current management of hepatocellular carcinoma.
@en
Current management of hepatocellular carcinoma.
@nl
type
label
Current management of hepatocellular carcinoma.
@ast
Current management of hepatocellular carcinoma.
@en
Current management of hepatocellular carcinoma.
@nl
prefLabel
Current management of hepatocellular carcinoma.
@ast
Current management of hepatocellular carcinoma.
@en
Current management of hepatocellular carcinoma.
@nl
P2860
P1476
Current management of hepatocellular carcinoma.
@en
P2093
Ana Maria Crissien
Catherine Frenette
P2860
P304
P577
2014-03-01T00:00:00Z